Immutep Limited (ASX:IMM)
Australia · Delayed Price · Currency is AUD 0.3800
-0.0050 (-1.30%)
Feb 5, 2026, 4:10 PM AEST
Immutep Market Cap
Immutep has a market cap or net worth of 560.01 million as of February 5, 2026. Its market cap has increased by 16.59% in one year.
Market Cap
560.01M
Enterprise Value
431.95M
Revenue
5.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.38
Market Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 560.01M, an increase of 15,188.55%. That is a compound annual growth rate of 18.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 560.01M | -8.43% |
| Dec 31, 2025 | 611.59M | 15.11% |
| Dec 31, 2024 | 531.29M | 29.54% |
| Dec 29, 2023 | 410.15M | 69.62% |
| Dec 30, 2022 | 241.81M | -42.22% |
| Dec 31, 2021 | 418.52M | 55.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 1.85B |
| Clarity Pharmaceuticals | 1.04B |
| PYC Therapeutics | 880.72M |
| Opthea | 738.77M |
| Clinuvel Pharmaceuticals | 591.87M |
| Racura Oncology | 415.62M |
| Dimerix | 309.20M |
| Orthocell | 249.60M |